GFAP and brain neoplasm: In a previous study, Koszewicz et al. [23] found that anti-neuroendothelium, anti-GFAP, anti-MAG, anti-PCNA, and anti-Ro52 antibodies were associated with peripheral nerve alterations in patients with brain tumours.